Paget’s disease of the vulva is a rare skin condition that affects the external female genital area, often appearing as a red, scaly rash that can be confused with common skin problems. Understanding what to expect with this condition can help patients and families navigate the journey ahead with greater confidence and clarity.

Prognosis and Survival Outlook

When women receive a diagnosis of Paget’s disease of the vulva, questions about the future naturally arise. The outlook for this condition depends largely on whether the disease is limited to the surface skin layers or has invaded deeper tissues, and whether there are any associated cancers elsewhere in the body. For many women, the news brings a mixture of relief and concern, as the prognosis is generally more favorable than many other types of cancer^[4].

Women with Paget’s disease of the vulva who do not have invasive cancer typically have an excellent long-term survival rate. Studies show that the five-year survival rate approaches 90% for patients with this type of presentation^[4]. This statistic means that nine out of ten women diagnosed with non-invasive disease are alive five years after diagnosis, which is genuinely encouraging. The disease tends to grow slowly, often taking years before it causes noticeable symptoms or spreads beyond the skin surface^[3].

However, the picture changes when Paget’s disease is found alongside invasive cancer or when it has spread to underlying tissues. In these situations, which affect between 10 and 30 percent of patients with Paget’s disease of the vulva, the condition becomes more aggressive and the risk of recurrence increases^[5]. The presence of an associated cancer can also increase the risk of death. Women whose disease has invaded the dermis (the deeper layer of skin beneath the surface) or spread to lymph nodes face more serious challenges^[3].

About 7 to 40 percent of women with extramammary Paget’s disease have an underlying cancer in another part of their body^[3]. This means that even when the visible vulvar lesion seems manageable, there may be hidden health concerns requiring attention. Healthcare providers typically recommend screening for cancers of the breast, colon, bladder, cervix, and other organs when Paget’s disease of the vulva is diagnosed^[4].

Age and overall health also influence prognosis. Paget’s disease of the vulva primarily affects women between 50 and 80 years old, with most cases occurring in postmenopausal women^[3]. Older patients or those with other serious health conditions may face additional challenges during treatment and recovery.

Natural Progression Without Treatment

Understanding how Paget’s disease of the vulva develops when left untreated helps explain why early intervention matters. This condition typically begins as abnormal cells within the top layer of skin called the epidermis. In its earliest stages, these cells remain confined to the surface, where they can be seen as red, scaly patches that might resemble eczema or other benign skin conditions^[3].

The disease spreads in a way that can be difficult to predict. The abnormal Paget cells often extend far beyond what is visible to the naked eye, creeping through the skin in patterns that don’t follow clear boundaries^[4]. This invisible spread is one reason why diagnosis is frequently delayed—the rash may look small and harmless while the microscopic changes extend much further. Women often experience symptoms such as itching, burning, and irritation for two years or more before the correct diagnosis is made^[5].

If Paget’s disease remains undiagnosed and untreated, several things can happen over time. The affected area may gradually enlarge, and the skin changes can become more pronounced. The initially red and scaly patches may develop a white coating that has been described as resembling “cake frosting” or “cupcake icing”^[4][5]. As the condition progresses, the skin may thicken, and deeper sores called ulcers or raised bumps called nodules may form^[3].

In some cases, the Paget cells eventually break through the basement membrane—a thin layer separating the epidermis from the dermis below. When this invasion occurs, the disease takes on a more serious character. The cells can then access blood vessels and lymphatic channels, creating pathways for spread to other parts of the body. Occasionally, Paget cells extend from the epidermis into the dermis and can cause metastases, or spread to distant organs, usually beginning with the regional lymph nodes in the groin^[5].

The lungs, bones, adrenal glands, and liver are potential sites where the disease might spread, although this is relatively uncommon^[5]. The slow-growing nature of vulvar Paget’s disease means that even without treatment, progression may take many years. However, the longer the disease remains untreated, the greater the chance that it will become invasive or that symptoms will worsen significantly.

Another concerning aspect of the natural history is the association with other cancers. Some cases of Paget’s disease of the vulva are actually secondary, meaning they arise because of cancer in a nearby organ such as the bladder, urethra, rectum, or cervix^[3]. In these situations, the vulvar changes are a manifestation of a more serious underlying problem. One-third of secondary extramammary Paget’s disease cases result from rectal cancer^[3]. Without proper diagnosis and treatment, these hidden cancers can progress unchecked.

Possible Complications

Women living with Paget’s disease of the vulva face several potential complications that can develop both from the disease itself and from the treatments used to manage it. These complications can be physical, affecting the body’s structure and function, or they can impact emotional well-being and quality of life.

One of the most challenging complications is the high rate of recurrence. Studies show that between 33 and 60 percent of women experience the disease coming back after wide local excision, even when surgeons believe they have removed all affected tissue^[4]. Some sources indicate that as many as 47 percent of patients will have recurrence^[11]. In one study, 18 percent of patients had four or more recurrences, requiring repeated surgeries over many years^[19]. This pattern of recurrence happens because the disease is often multifocal, meaning it appears in multiple spots, and the margins extend irregularly beyond what can be seen clinically^[4].

The repeated surgeries necessary to manage recurrent disease lead to progressive destruction of normal vulvar anatomy. Over a 10 to 20 year period, multiple local excisions can result in significant disfigurement^[4]. Women may lose the natural shape and appearance of their external genitalia, which can profoundly affect body image, self-esteem, and sexual function. Some women eventually require complete removal of the vulva, called a vulvectomy, followed by skin grafting to reconstruct the area^[4].

Surgical complications themselves can add to the burden. Large excisions or vulvectomy often require complex reconstruction involving both gynecologic oncologists and plastic surgeons working together^[4]. Healing can be difficult in the vulvar region due to moisture, friction, and proximity to the urinary and anal openings. Women may experience chronic pain, scarring, difficulty with urination or bowel movements, and problems with sexual intimacy after extensive surgery.

Positive surgical margins—meaning that abnormal cells are found at the edge of the removed tissue—occur in more than half of cases, with some studies reporting rates as high as 70 percent^[4][19]. Interestingly, research has found no clear association between positive margins and recurrence, suggesting that the disease’s behavior is more complex than simple incomplete removal^[19]. This finding adds to the frustration patients and doctors face when trying to prevent recurrence.

Invasion into deeper tissue layers represents another serious complication. When Paget cells break through into the dermis or invade underlying structures, the risk of spread to lymph nodes increases^[4]. Seven to eight percent of women are eventually found to have invasive cancer within the vulvar tissue^[19]. Once lymph node involvement occurs, the disease becomes much more difficult to treat and the prognosis worsens considerably.

A significant proportion of women with Paget’s disease of the vulva—approximately 46 percent in one study—develop other cancers either at the same time (synchronous) or later (metachronous)^[19]. These can include cancers of the breast, colon, bladder, cervix, uterus, and other organs. The need for ongoing screening and surveillance for multiple cancer types adds to the medical complexity and psychological burden these women face.

Non-surgical treatments, while less mutilating than repeated operations, carry their own complications. Topical medications such as imiquimod, fluorouracil, and bleomycin can cause significant skin reactions including pain, peeling (desquamation), and ulceration^[4]. Laser therapy and photodynamic therapy similarly cause skin complications that can be uncomfortable and temporarily disabling^[4]. Radiation therapy, sometimes used when surgery is not feasible, can damage normal tissues and cause long-term changes to the skin and underlying structures^[6].

Impact on Daily Life

Living with Paget’s disease of the vulva affects women in ways that extend far beyond the physical symptoms. The disease touches every aspect of daily life, from the most intimate personal activities to social interactions, work responsibilities, and emotional well-being. Understanding these impacts helps patients and their families prepare for the challenges ahead and develop strategies for maintaining the best possible quality of life.

The physical symptoms themselves create immediate daily challenges. Itching is the most common symptom, and it can be relentless and severe^[8]. The constant urge to scratch can interfere with sleep, concentration at work, and participation in social activities. Women often describe long-standing itching that has been present for years before diagnosis, with various treatments providing little relief^[8]. Burning, pain, and tenderness in the vulvar area make sitting for long periods uncomfortable and can affect a woman’s ability to perform her job, especially if it requires prolonged sitting^[3].

Sexual intimacy becomes profoundly affected. The vulvar changes, including redness, scaling, and sometimes bleeding or discharge, can make women feel self-conscious about their bodies^[6]. Pain during intercourse is common, and the fear of worsening symptoms or causing injury can lead to avoidance of sexual activity altogether. For women in relationships, this creates strain and requires open communication with partners about physical limitations and emotional needs. The progressive disfigurement that can result from repeated surgeries further impacts sexual identity and confidence.

Emotional and psychological effects are substantial. Many women experience delayed diagnosis because the symptoms are initially attributed to more common, benign conditions such as eczema or yeast infections. This delay, which averages two years or more, often leaves women feeling frustrated, dismissed, or worried that their concerns are not being taken seriously^[5]. Once diagnosed with a rare form of cancer, women may feel isolated and find it difficult to locate others who understand their experience.

The chronic, relapsing nature of the disease creates ongoing anxiety. Even after successful treatment, the high recurrence rate means women must remain vigilant, attend regular follow-up appointments, and live with uncertainty about the future. Some studies show that 18 percent of patients have four or more recurrences^[19], meaning the disease becomes a long-term companion requiring repeated interventions over decades. This chronic disease state affects life planning, career decisions, and emotional stability.

Treatment side effects add another layer of disruption to daily life. Surgery in the vulvar area requires time for healing, during which women must limit physical activity, avoid tight clothing, manage wound care, and often take time off work. The healing process can be complicated by the location—keeping the area clean and dry while still managing normal urinary and bowel functions presents daily challenges. Women may need to modify bathroom routines, change how they manage menstruation if they are premenopausal, and adjust their clothing choices.

For women undergoing topical treatments such as imiquimod, the application process itself can be uncomfortable, and the resulting skin reactions—including pain, ulceration, and peeling—can be severe enough to interfere with daily activities^[4]. These treatments typically require weeks or months of application, during which time symptoms may actually worsen before improving.

Social activities may be affected by both physical symptoms and emotional distress. Women might avoid swimming, exercise classes, or other activities where changing clothes in front of others is required. The constant awareness of an intimate health problem can make casual social interactions feel strained, especially if symptoms like itching or pain flare up unexpectedly.

Financial impacts can be significant. Paget’s disease of the vulva requires ongoing medical care including frequent doctor visits, biopsies, imaging studies, and treatments. Women may face costs related to multiple surgeries, medications, and time away from work. The need for screening for other cancers adds to the medical expenses and time commitment^[4].

Work life may require adjustments depending on the severity of symptoms and treatment schedule. Women might need to request accommodations such as more flexible hours for medical appointments, the ability to work from home during recovery periods, or modifications to their workspace to reduce discomfort. For some women, especially those whose work involves physical labor or prolonged standing, symptoms may affect job performance or even force career changes.

Hobbies and recreational activities that were once enjoyable may become difficult. Activities involving cycling, horseback riding, or prolonged sitting might need to be modified or temporarily stopped. Women who find pleasure in physical exercise may need to explore gentler options such as swimming (when healing allows) or upper-body workouts that don’t place pressure on the affected area.

Support for Family Members

When a woman receives a diagnosis of Paget’s disease of the vulva, her family members often feel uncertain about how best to help. The intimate nature of vulvar disease can make open discussion difficult, yet family support plays a crucial role in helping patients navigate the medical system, make informed decisions about treatment, and cope with the emotional challenges that arise.

Understanding the disease is the first step for family members. Paget’s disease of the vulva is rare, representing only 1 to 2 percent of all vulvar cancers^[4]. Because of its rarity, many people, including some healthcare providers, may not be familiar with it. Family members can help by learning about the condition alongside the patient, attending medical appointments when appropriate, and asking questions when information is unclear.

Clinical trials may offer access to promising new treatments for Paget’s disease of the vulva. However, because the disease is so uncommon, clinical trials specifically for this condition are scarce. Family members can assist by helping research available trials, which might be found through cancer centers, academic medical institutions, or online registries. The process of finding and enrolling in a clinical trial can be complex and time-consuming, requiring coordination with multiple healthcare providers, review of eligibility criteria, and sometimes travel to specialized centers.

When considering clinical trial participation, families should understand several key points. Clinical trials are research studies designed to test new treatments or approaches to care. They follow strict protocols and include various safeguards to protect participants. However, trials also involve uncertainty—the experimental treatment may not work better than standard care, and there may be unknown side effects. Patients enrolled in trials typically receive very close medical monitoring and may have access to treatments not yet available to the general public.

Families can help their loved one evaluate whether trial participation makes sense by discussing questions such as: What are the potential benefits and risks? What is the time commitment? Will insurance cover associated costs? How does this compare to standard treatment options? Is the trial location accessible? What happens if the treatment doesn’t work or causes problems?

Preparing for trial participation involves practical steps where family support proves invaluable. Someone needs to organize medical records, ensure all required tests and screenings are completed, arrange transportation to the study site, and help track appointments and follow-up requirements. Many trials require frequent visits, especially in early phases, which can be exhausting for the patient. A family member who can drive, take notes during appointments, or simply provide companionship makes the process more manageable.

Beyond clinical trials, family members support their loved ones in numerous other ways. Emotional support is perhaps most critical. Women with Paget’s disease may feel embarrassed about discussing their condition due to its intimate location. They may worry about changes to their body and how these will affect relationships. Family members can help by listening without judgment, offering reassurance, and respecting the patient’s privacy while still being available to help when needed.

Practical assistance with daily tasks becomes especially important during treatment periods. After vulvar surgery, women need time to heal and may have difficulty with basic activities such as sitting, walking, using the bathroom, or caring for surgical wounds. Family members can help with meal preparation, household chores, childcare if applicable, and wound care if the patient is comfortable with assistance.

Attending medical appointments together provides multiple benefits. An additional person can help remember what the doctor says, ask questions the patient might not think of, and provide emotional support during difficult conversations. Because treatment decisions for Paget’s disease are complex—involving choices between surgery, topical treatments, radiation, or watchful waiting—having a family member present to help weigh options can be valuable.

Family members should be aware that Paget’s disease requires long-term monitoring even after successful treatment, given the high recurrence rates. Supporting regular follow-up care, helping track symptoms, and encouraging the patient to report new concerns promptly are all important roles for family. Similarly, because women with Paget’s disease need screening for other cancers, families can help ensure these appointments happen and provide transportation and companionship.

Respecting boundaries is equally important. The vulvar area is private, and not all women will want to discuss details or accept help with personal care. Family members should follow the patient’s lead about what kind of support is welcome. Some women prefer to manage intimate care independently and may only want help with logistics, meal preparation, or emotional support.

For partners specifically, open communication about sexual intimacy is essential. Paget’s disease and its treatments often affect sexual function and body image. Partners should be patient, understanding, and willing to explore alternative forms of intimacy during healing periods. Professional counseling for couples dealing with the impact of illness on their relationship can be beneficial.

Caregivers themselves need support. Watching a loved one struggle with a chronic condition, especially one that may recur repeatedly, takes an emotional toll. Family members should acknowledge their own needs, seek support from friends or support groups, and take breaks when needed to avoid burnout.